Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Other Working Capital Changes (2022 - 2025)

Coya Therapeutics (COYA) has disclosed Other Working Capital Changes for 4 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes rose 181.98% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $454247.0 through Dec 2025, up 53.49% year-over-year, with the annual reading at $454247.0 for FY2025, 53.49% up from the prior year.
  • Other Working Capital Changes hit $2.5 million in Q4 2025 for Coya Therapeutics, up from $224625.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $3.1 million in Q3 2024 to a low of -$3.1 million in Q1 2025.
  • Historically, Other Working Capital Changes has averaged $93030.1 across 4 years, with a median of $60151.5 in 2022.
  • Biggest five-year swings in Other Working Capital Changes: surged 2233.67% in 2023 and later plummeted 2414.9% in 2024.
  • Year by year, Other Working Capital Changes stood at $1.2 million in 2022, then plummeted by 88.86% to $133203.0 in 2023, then tumbled by 2414.9% to -$3.1 million in 2024, then skyrocketed by 181.98% to $2.5 million in 2025.
  • Business Quant data shows Other Working Capital Changes for COYA at $2.5 million in Q4 2025, $224625.0 in Q3 2025, and $827695.0 in Q2 2025.